CLINICAL_TRIALS
trial_result
· 2015-11-02
Clinical Trial Update: A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001) [Phase 2]
Summary
A Phase 2 study of MK0140 in diabetic patients with macular edema has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Macular Edema | Phase 2 | Status: TERMINATED